February 23, 2012

The Food and Drug Administration has accepted a new drug application for the treatment of idiopathic Parkinson’s disease.

January 18, 2012

The Food and Drug Administration has provided guidance to Provectus Pharmaceuticals as the drug maker prepares to apply with the agency for approval to start a late-stage clinical trial of a drug for skin cancer, Provectus said Wednesday.

December 7, 2011

A drug in late-stage clinical trials appears to treat the symptoms of autism, the drug's developer said Wednesday.

June 3, 2011

Swedish drug maker Diamyd Medical has regained control of its investigational drug for Type 1 diabetes following Johnson & Johnson’s termination of a development deal between the two companies.

May 10, 2011

The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.

May 10, 2011

The branded-drug division of Impax Labs plans to conduct early-stage clinical studies of an investigational drug for restless leg syndrome, the company said Tuesday.

April 1, 2011

An investigational drug for Parkinson’s disease was safe and effective, according to results of a late-stage clinical trial scheduled for presentation next week.

March 8, 2011

The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.

February 14, 2011

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

January 19, 2011

Patients taking an investigational drug made by Genentech for advanced skin cancer fared better than those receiving standard treatments, according to results of a late-stage clinical trial announced Wednesday.

November 14, 2010

An investigational drug made by Johnson & Johnson is more effective in reducing the risk...

September 28, 2010

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

August 29, 2010

BioMarin Pharmaceutical on Monday announced its investigational treatment for a lysosomal storage disorder has received...

August 18, 2010

The Food and Drug Administration has decided to expedite the review of an investigational drug...

August 11, 2010

An investigational drug made by Pharmasset for treating hepatitis C will get expedited review from...

July 20, 2010

Fera Pharmaceuticals has acquired rights to an investigational drug for treating a rare fungal ear...

June 23, 2010

Reports of worsening conditions among patients has led drug maker Pfizer to suspend a clinical...

June 14, 2010

An investigational drug for treating multiple sclerosis has a shot at becoming a top seller,...

March 17, 2010

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 9, 2010

A Food and Drug Administration committee has recommended approval for an investigational drug for treating...

February 28, 2010

Merck & Co.’s acquisition of Schering-Plough has delivered a big boost to the drug maker’s...

February 16, 2010

Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...

January 20, 2010

An investigational drug for treating dry eye didn’t work as well as its developers hoped,...